Software - Application
Compare Stocks
5 / 10Stock Comparison
RSKD vs FICO vs TRU vs VRNT vs NICE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Consulting Services
Software - Infrastructure
Software - Application
RSKD vs FICO vs TRU vs VRNT vs NICE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Consulting Services | Software - Infrastructure | Software - Application |
| Market Cap | $825M | $26.20B | $14.07B | $1.24B | $5.78B |
| Revenue (TTM) | $345M | $2.26B | $4.73B | $894M | $2.95B |
| Net Income (TTM) | $-28M | $760M | $705M | $61M | $612M |
| Gross Margin | 51.5% | 84.2% | 52.7% | 69.9% | 66.4% |
| Operating Margin | -9.8% | 50.4% | 18.1% | 8.6% | 21.9% |
| Forward P/E | 20.8x | 26.4x | 15.3x | 7.0x | 8.7x |
| Total Debt | $25M | $3.07B | $5.16B | $448M | $164M |
| Cash & Equiv. | $162M | $134M | $854M | $216M | $379M |
RSKD vs FICO vs TRU vs VRNT vs NICE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Riskified Ltd. (RSKD) | 100 | 17.6 | -82.4% |
| Fair Isaac Corporat… (FICO) | 100 | 215.6 | +115.6% |
| TransUnion (TRU) | 100 | 60.8 | -39.2% |
| Verint Systems Inc. (VRNT) | 100 | 47.5 | -52.5% |
| NICE Ltd. (NICE) | 100 | 34.3 | -65.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RSKD vs FICO vs TRU vs VRNT vs NICE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RSKD lags the leaders in this set but could rank higher in a more targeted comparison.
FICO carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 15.9%, EPS growth 29.8%, 3Y rev CAGR 13.1%
- 9.5% 10Y total return vs TRU's 142.0%
- 15.9% revenue growth vs VRNT's -0.1%
- 33.7% margin vs RSKD's -8.0%
Among these 5 stocks, TRU doesn't own a clear edge in any measured category.
VRNT is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 1.26, yield 1.6%
- Beta 1.26, yield 1.6%, current ratio 1.12x
- 1.6% yield, vs TRU's 0.6%, (3 stocks pay no dividend)
- +17.9% vs FICO's -46.1%
NICE ranks third and is worth considering specifically for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- PEG 0.33 vs TRU's 2.87
- Lower P/E (8.7x vs 15.3x), PEG 0.33 vs 2.87
- Beta 0.72 vs TRU's 1.36, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.9% revenue growth vs VRNT's -0.1% | |
| Value | Lower P/E (8.7x vs 15.3x), PEG 0.33 vs 2.87 | |
| Quality / Margins | 33.7% margin vs RSKD's -8.0% | |
| Stability / Safety | Beta 0.72 vs TRU's 1.36, lower leverage | |
| Dividends | 1.6% yield, vs TRU's 0.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +17.9% vs FICO's -46.1% | |
| Efficiency (ROA) | 39.8% ROA vs RSKD's -6.3%, ROIC 59.7% vs -22.2% |
RSKD vs FICO vs TRU vs VRNT vs NICE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RSKD vs FICO vs TRU vs VRNT vs NICE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FICO leads in 2 of 6 categories
RSKD leads 0 • TRU leads 0 • VRNT leads 0 • NICE leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FICO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TRU is the larger business by revenue, generating $4.7B annually — 13.7x RSKD's $345M. FICO is the more profitable business, keeping 33.7% of every revenue dollar as net income compared to RSKD's -8.0%. On growth, FICO holds the edge at +38.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $345M | $2.3B | $4.7B | $894M | $2.9B |
| EBITDAEarnings before interest/tax | -$27M | $1.2B | $1.4B | $127M | $845M |
| Net IncomeAfter-tax profit | -$28M | $760M | $705M | $61M | $612M |
| Free Cash FlowCash after capex | $34M | $893M | $697M | $118M | $665M |
| Gross MarginGross profit ÷ Revenue | +51.5% | +84.2% | +52.7% | +69.9% | +66.4% |
| Operating MarginEBIT ÷ Revenue | -9.8% | +50.4% | +18.1% | +8.6% | +21.9% |
| Net MarginNet income ÷ Revenue | -8.0% | +33.7% | +14.9% | +6.9% | +20.8% |
| FCF MarginFCF ÷ Revenue | +9.9% | +39.6% | +14.7% | +13.2% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +38.7% | +13.7% | -1.0% | +9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.5% | +69.0% | +172.0% | -5.1% | +56.5% |
Valuation Metrics
Evenly matched — VRNT and NICE each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 77% valuation discount to FICO's 42.6x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.37x vs TRU's 5.91x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $825M | $26.2B | $14.1B | $1.2B | $5.8B |
| Enterprise ValueMkt cap + debt − cash | $687M | $29.1B | $18.4B | $1.5B | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | -26.81x | 42.57x | 31.44x | 19.72x | 9.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.80x | 26.43x | 15.28x | 7.00x | 8.74x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.55x | 5.91x | 1.02x | 0.37x |
| EV / EBITDAEnterprise value multiple | — | 31.01x | 12.83x | 9.46x | 6.59x |
| Price / SalesMarket cap ÷ Revenue | 2.39x | 13.16x | 3.08x | 1.37x | 1.96x |
| Price / BookPrice ÷ Book value/share | 2.58x | — | 3.16x | 0.97x | 1.56x |
| Price / FCFMarket cap ÷ FCF | 24.94x | 34.03x | 21.27x | 8.75x | 8.22x |
Profitability & Efficiency
Evenly matched — FICO and NICE each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-8 for RSKD. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TRU's 1.13x. On the Piotroski fundamental quality scale (0–9), TRU scores 8/9 vs RSKD's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.4% | — | +15.1% | +4.6% | +16.4% |
| ROA (TTM)Return on assets | -6.3% | +39.8% | +6.2% | +2.8% | +11.8% |
| ROICReturn on invested capital | -22.2% | +59.7% | +7.3% | +5.3% | +13.2% |
| ROCEReturn on capital employed | -7.6% | +78.5% | +8.6% | +5.9% | +16.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 8 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.08x | — | 1.13x | 0.34x | 0.04x |
| Net DebtTotal debt minus cash | -$137M | $2.9B | $4.3B | $233M | -$216M |
| Cash & Equiv.Liquid assets | $162M | $134M | $854M | $216M | $379M |
| Total DebtShort + long-term debt | $25M | $3.1B | $5.2B | $448M | $164M |
| Interest CoverageEBIT ÷ Interest expense | — | 7.20x | 3.61x | 8.24x | — |
Total Returns (Dividends Reinvested)
FICO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FICO five years ago would be worth $22,769 today (with dividends reinvested), compared to $1,856 for RSKD. Over the past 12 months, VRNT leads with a +17.9% total return vs FICO's -46.1%. The 3-year compound annual growth rate (CAGR) favors FICO at 15.3% vs NICE's -20.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.3% | -31.3% | -12.3% | — | -14.6% |
| 1-Year ReturnPast 12 months | +2.0% | -46.1% | -13.9% | +17.9% | -40.4% |
| 3-Year ReturnCumulative with dividends | +2.2% | +53.4% | +13.9% | -39.3% | -49.3% |
| 5-Year ReturnCumulative with dividends | -81.4% | +127.7% | -29.3% | -56.1% | -59.1% |
| 10-Year ReturnCumulative with dividends | -81.4% | +949.1% | +142.0% | -37.1% | +50.7% |
| CAGR (3Y)Annualised 3-year return | +0.7% | +15.3% | +4.4% | -15.3% | -20.2% |
Risk & Volatility
Evenly matched — VRNT and NICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than TRU's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRNT currently trades 89.8% from its 52-week high vs FICO's 50.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.86x | 1.36x | 1.26x | 0.72x |
| 52-Week HighHighest price in past year | $5.68 | $2217.60 | $99.39 | $22.84 | $180.61 |
| 52-Week LowLowest price in past year | $3.70 | $870.01 | $65.23 | $16.23 | $94.89 |
| % of 52W HighCurrent price vs 52-week peak | +84.9% | +50.9% | +73.4% | +89.8% | +53.0% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 50.9 | 47.2 | 68.4 | 40.9 |
| Avg Volume (50D)Average daily shares traded | 763K | 371K | 2.3M | 0 | 631K |
Analyst Outlook
Evenly matched — TRU and VRNT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RSKD as "Buy", FICO as "Buy", TRU as "Buy", VRNT as "Hold", NICE as "Buy". Consensus price targets imply 58.8% upside for VRNT (target: $33) vs 19.2% for RSKD (target: $6). For income investors, VRNT offers the higher dividend yield at 1.56% vs TRU's 0.63%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $5.75 | $1649.11 | $94.88 | $32.57 | $150.88 |
| # AnalystsCovering analysts | 11 | 18 | 26 | 16 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.6% | +1.6% | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — | $0.46 | $0.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +12.9% | +5.4% | +2.4% | +5.8% | +8.5% |
FICO leads in 2 of 6 categories — strongest in Income & Cash Flow and Total Returns. 4 categories are tied.
RSKD vs FICO vs TRU vs VRNT vs NICE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RSKD or FICO or TRU or VRNT or NICE a better buy right now?
For growth investors, Fair Isaac Corporation (FICO) is the stronger pick with 15.
9% revenue growth year-over-year, versus -0. 1% for Verint Systems Inc. (VRNT). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Riskified Ltd. (RSKD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RSKD or FICO or TRU or VRNT or NICE?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Fair Isaac Corporation at 42. 6x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 33x versus TransUnion's 2. 87x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RSKD or FICO or TRU or VRNT or NICE?
Over the past 5 years, Fair Isaac Corporation (FICO) delivered a total return of +127.
7%, compared to -81. 4% for Riskified Ltd. (RSKD). Over 10 years, the gap is even starker: FICO returned +949. 1% versus RSKD's -81. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RSKD or FICO or TRU or VRNT or NICE?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus TransUnion's 1. 36β — meaning TRU is approximately 88% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 113% for TransUnion — giving it more financial flexibility in a downturn.
05Which is growing faster — RSKD or FICO or TRU or VRNT or NICE?
By revenue growth (latest reported year), Fair Isaac Corporation (FICO) is pulling ahead at 15.
9% versus -0. 1% for Verint Systems Inc. (VRNT). On earnings-per-share growth, the picture is similar: Verint Systems Inc. grew EPS 271. 4% year-over-year, compared to 10. 0% for Riskified Ltd.. Over a 3-year CAGR, FICO leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RSKD or FICO or TRU or VRNT or NICE?
Fair Isaac Corporation (FICO) is the more profitable company, earning 32.
7% net margin versus -8. 0% for Riskified Ltd. — meaning it keeps 32. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FICO leads at 46. 5% versus -8. 4% for RSKD. At the gross margin level — before operating expenses — FICO leads at 82. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RSKD or FICO or TRU or VRNT or NICE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 33x versus TransUnion's 2. 87x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verint Systems Inc. (VRNT) trades at 7. 0x forward P/E versus 26. 4x for Fair Isaac Corporation — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRNT: 58. 8% to $32. 57.
08Which pays a better dividend — RSKD or FICO or TRU or VRNT or NICE?
In this comparison, VRNT (1.
6% yield), TRU (0. 6% yield) pay a dividend. RSKD, FICO, NICE do not pay a meaningful dividend and should not be held primarily for income.
09Is RSKD or FICO or TRU or VRNT or NICE better for a retirement portfolio?
For long-horizon retirement investors, Fair Isaac Corporation (FICO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), +949. 1% 10Y return). Both have compounded well over 10 years (FICO: +949. 1%, RSKD: -81. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RSKD and FICO and TRU and VRNT and NICE?
These companies operate in different sectors (RSKD (Technology) and FICO (Technology) and TRU (Industrials) and VRNT (Technology) and NICE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RSKD is a small-cap quality compounder stock; FICO is a mid-cap high-growth stock; TRU is a mid-cap quality compounder stock; VRNT is a small-cap quality compounder stock; NICE is a small-cap deep-value stock. TRU, VRNT pay a dividend while RSKD, FICO, NICE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.